Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: A randomised, double-blind, multicentre study

Mark Q. Niederauer, Joel E. Michalek, Qianqian Liu, Klearchos K. Papas, Lawrence A. Lavery, David G. Armstrong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The aim of this study was to assess whether continuous diffusion of oxygen improves healing in people receiving treatment for diabetic foot ulcers (DFU). Method: A double-blind, placebo control randomised study to receive either active continuous diffusion of oxygen (CDO) therapy using an active CDO device, or a fully operational placebo device without delivering oxygen. Patients were followed until closure or 12 weeks. Patients, caretakers, treating physicians and independent evaluators were blinded to the study arm. All patients received identical offloading, debridement, dressings and follow-up. Results: We enrolled 146 people with DFUs (77% male, aged 56.312.4 years). A significantly higher proportion (195%) of DFUs healed in the CDO arm compared with placebo (32.4% versus 16.7%, p=0.033). The time to 50% DFU closure was significantly shorter in patients that received CDO therapy (mean 18.4 versus 28.9 days, p=0.001). There were no differences in overall adverse events (p=0.66) or ulcer-related adverse events (p=0.30) in the active and placebo treatment groups. The relative performance of active CDO over placebo became greater when used in larger wounds (273%), in more chronic wounds (334%) and in weight bearing wounds (465%). Conclusion: The results of this study demonstrate that CDO leads to higher proportion of healed DFUs (p=0.033) and a faster time to closure compared with placebo in people with DFUs (p=0.015). Relative performance did not vary significantly with wound size (p=0.80), but revealed better relative performance in more chronic wounds (p=0.008) and in weight-bearing wounds (p=0.003). Declaration of interest: MQN is a full-time employee of EO2 Concepts. DGA and LAL are a member of the scientific advisory board of EO2 concepts. The other authors have no conflict of interest to declare.

Original languageEnglish (US)
Pages (from-to)S30-S45
JournalJournal of wound care
Volume27
DOIs
StatePublished - Sep 1 2018

Fingerprint

Diabetic Foot
Double-Blind Method
Multicenter Studies
Placebos
Oxygen
Wounds and Injuries
Weight-Bearing
Conflict of Interest
Equipment and Supplies
Debridement
Therapeutics
Bandages
Ulcer
Physicians

Keywords

  • closure rate
  • continuous diffusion of oxygen
  • diabetic foot ulcer
  • moist wound therapy
  • tissue oxygenation
  • wound healing

ASJC Scopus subject areas

  • Fundamentals and skills
  • Nursing (miscellaneous)

Cite this

Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control : A randomised, double-blind, multicentre study. / Niederauer, Mark Q.; Michalek, Joel E.; Liu, Qianqian; Papas, Klearchos K.; Lavery, Lawrence A.; Armstrong, David G.

In: Journal of wound care, Vol. 27, 01.09.2018, p. S30-S45.

Research output: Contribution to journalArticle

Niederauer, Mark Q. ; Michalek, Joel E. ; Liu, Qianqian ; Papas, Klearchos K. ; Lavery, Lawrence A. ; Armstrong, David G. / Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control : A randomised, double-blind, multicentre study. In: Journal of wound care. 2018 ; Vol. 27. pp. S30-S45.
@article{92859c0adde24fd29a52872106650934,
title = "Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: A randomised, double-blind, multicentre study",
abstract = "Objective: The aim of this study was to assess whether continuous diffusion of oxygen improves healing in people receiving treatment for diabetic foot ulcers (DFU). Method: A double-blind, placebo control randomised study to receive either active continuous diffusion of oxygen (CDO) therapy using an active CDO device, or a fully operational placebo device without delivering oxygen. Patients were followed until closure or 12 weeks. Patients, caretakers, treating physicians and independent evaluators were blinded to the study arm. All patients received identical offloading, debridement, dressings and follow-up. Results: We enrolled 146 people with DFUs (77{\%} male, aged 56.312.4 years). A significantly higher proportion (195{\%}) of DFUs healed in the CDO arm compared with placebo (32.4{\%} versus 16.7{\%}, p=0.033). The time to 50{\%} DFU closure was significantly shorter in patients that received CDO therapy (mean 18.4 versus 28.9 days, p=0.001). There were no differences in overall adverse events (p=0.66) or ulcer-related adverse events (p=0.30) in the active and placebo treatment groups. The relative performance of active CDO over placebo became greater when used in larger wounds (273{\%}), in more chronic wounds (334{\%}) and in weight bearing wounds (465{\%}). Conclusion: The results of this study demonstrate that CDO leads to higher proportion of healed DFUs (p=0.033) and a faster time to closure compared with placebo in people with DFUs (p=0.015). Relative performance did not vary significantly with wound size (p=0.80), but revealed better relative performance in more chronic wounds (p=0.008) and in weight-bearing wounds (p=0.003). Declaration of interest: MQN is a full-time employee of EO2 Concepts. DGA and LAL are a member of the scientific advisory board of EO2 concepts. The other authors have no conflict of interest to declare.",
keywords = "closure rate, continuous diffusion of oxygen, diabetic foot ulcer, moist wound therapy, tissue oxygenation, wound healing",
author = "Niederauer, {Mark Q.} and Michalek, {Joel E.} and Qianqian Liu and Papas, {Klearchos K.} and Lavery, {Lawrence A.} and Armstrong, {David G.}",
year = "2018",
month = "9",
day = "1",
doi = "10.12968/jowc.2018.27.Sup9.S30",
language = "English (US)",
volume = "27",
pages = "S30--S45",
journal = "Journal of wound care",
issn = "0969-0700",
publisher = "MA Healthcare Ltd",

}

TY - JOUR

T1 - Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control

T2 - A randomised, double-blind, multicentre study

AU - Niederauer, Mark Q.

AU - Michalek, Joel E.

AU - Liu, Qianqian

AU - Papas, Klearchos K.

AU - Lavery, Lawrence A.

AU - Armstrong, David G.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Objective: The aim of this study was to assess whether continuous diffusion of oxygen improves healing in people receiving treatment for diabetic foot ulcers (DFU). Method: A double-blind, placebo control randomised study to receive either active continuous diffusion of oxygen (CDO) therapy using an active CDO device, or a fully operational placebo device without delivering oxygen. Patients were followed until closure or 12 weeks. Patients, caretakers, treating physicians and independent evaluators were blinded to the study arm. All patients received identical offloading, debridement, dressings and follow-up. Results: We enrolled 146 people with DFUs (77% male, aged 56.312.4 years). A significantly higher proportion (195%) of DFUs healed in the CDO arm compared with placebo (32.4% versus 16.7%, p=0.033). The time to 50% DFU closure was significantly shorter in patients that received CDO therapy (mean 18.4 versus 28.9 days, p=0.001). There were no differences in overall adverse events (p=0.66) or ulcer-related adverse events (p=0.30) in the active and placebo treatment groups. The relative performance of active CDO over placebo became greater when used in larger wounds (273%), in more chronic wounds (334%) and in weight bearing wounds (465%). Conclusion: The results of this study demonstrate that CDO leads to higher proportion of healed DFUs (p=0.033) and a faster time to closure compared with placebo in people with DFUs (p=0.015). Relative performance did not vary significantly with wound size (p=0.80), but revealed better relative performance in more chronic wounds (p=0.008) and in weight-bearing wounds (p=0.003). Declaration of interest: MQN is a full-time employee of EO2 Concepts. DGA and LAL are a member of the scientific advisory board of EO2 concepts. The other authors have no conflict of interest to declare.

AB - Objective: The aim of this study was to assess whether continuous diffusion of oxygen improves healing in people receiving treatment for diabetic foot ulcers (DFU). Method: A double-blind, placebo control randomised study to receive either active continuous diffusion of oxygen (CDO) therapy using an active CDO device, or a fully operational placebo device without delivering oxygen. Patients were followed until closure or 12 weeks. Patients, caretakers, treating physicians and independent evaluators were blinded to the study arm. All patients received identical offloading, debridement, dressings and follow-up. Results: We enrolled 146 people with DFUs (77% male, aged 56.312.4 years). A significantly higher proportion (195%) of DFUs healed in the CDO arm compared with placebo (32.4% versus 16.7%, p=0.033). The time to 50% DFU closure was significantly shorter in patients that received CDO therapy (mean 18.4 versus 28.9 days, p=0.001). There were no differences in overall adverse events (p=0.66) or ulcer-related adverse events (p=0.30) in the active and placebo treatment groups. The relative performance of active CDO over placebo became greater when used in larger wounds (273%), in more chronic wounds (334%) and in weight bearing wounds (465%). Conclusion: The results of this study demonstrate that CDO leads to higher proportion of healed DFUs (p=0.033) and a faster time to closure compared with placebo in people with DFUs (p=0.015). Relative performance did not vary significantly with wound size (p=0.80), but revealed better relative performance in more chronic wounds (p=0.008) and in weight-bearing wounds (p=0.003). Declaration of interest: MQN is a full-time employee of EO2 Concepts. DGA and LAL are a member of the scientific advisory board of EO2 concepts. The other authors have no conflict of interest to declare.

KW - closure rate

KW - continuous diffusion of oxygen

KW - diabetic foot ulcer

KW - moist wound therapy

KW - tissue oxygenation

KW - wound healing

UR - http://www.scopus.com/inward/record.url?scp=85053312338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053312338&partnerID=8YFLogxK

U2 - 10.12968/jowc.2018.27.Sup9.S30

DO - 10.12968/jowc.2018.27.Sup9.S30

M3 - Article

C2 - 30207844

AN - SCOPUS:85053312338

VL - 27

SP - S30-S45

JO - Journal of wound care

JF - Journal of wound care

SN - 0969-0700

ER -